EphB4-IN-2
EphB4-IN-2 is a tyrosine kinase inhibitor targeting the Eph family and Src family. EphB4-IN-2 binds to the ATP-binding site of the kinase domain of EphB4, and exhibits high affinity for tyrosine kinases with threonine as the gatekeeper residue, such as Abl, Lck and Src. EphB4-IN-2 can be used in research related to tumor-associated angiogenesis.
For research use only. We do not sell to patients.
- CAS No.: 1192216-03-7
- Formula: C22H19N5O4
- Molecular Weight:417.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
EPHB4 5 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DU-145 | IC50 |
2.7 μM
Compound: 3
|
Cytotoxicity against human PRXF DU145 cells after 4 days by propidium iodide staining
Cytotoxicity against human PRXF DU145 cells after 4 days by propidium iodide staining
|
[PMID: 23253074] |
| Hs-578T | GI50 |
562 nM
Compound: 3
|
Cytotoxicity against human Hs578T cells by SRB assay
Cytotoxicity against human Hs578T cells by SRB assay
|
[PMID: 23253074] |
| K562 | GI50 |
309 nM
Compound: 3
|
Cytotoxicity against human K562 cells by SRB assay
Cytotoxicity against human K562 cells by SRB assay
|
[PMID: 23253074] |
| MEF | IC50 |
130 nM
Compound: 3
|
Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA
Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA
|
[PMID: 23253074] |
| SNB-75 | GI50 |
128 nM
Compound: 3
|
Cytotoxicity against human SNB75 cells by SRB assay
Cytotoxicity against human SNB75 cells by SRB assay
|
[PMID: 23253074] |
In Vitro
EphB4-IN-2 (compound 66) potently inhibits recombinant EphB4 kinase activity in FRET-based enzymatic assays with an IC50 of 5 nM; it also inhibits this target in [γ-33P] ATP-based enzymatic assays, with an IC50 of 1.6 nM. This compound exhibits potent inhibitory effects on 9 out of 10 tested recombinant Eph receptor kinases, with corresponding IC50 values falling within the low nanomolar range of 1.1-15 nM, and only shows weak inhibitory activity against EphA7, with an IC50 of 1118 nM.
EphB4-IN-2 (1 μM; 30 minutes) potently inhibits recombinant EphA2, EphB3, Src, Lck and Yes1 kinases, exhibits moderate activity against CSK, BTK and HER-4, and shows only very low activity against most other tested kinases[1].
EphB4-IN-2 (1 μM) binds with high affinity to 15 kinases with small gatekeeper residues among the 49 tested recombinant kinases, and these kinases mainly belong to the Eph, Src and Abl families[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 1192216-03-7
-
Molecular Weight 417.42
-
Formula C22H19N5O4
-
SMILES
CN(C1=C2N3C(N(C4=C(OC)C=CC=C4)C(C5=CC(O)=CC=C5C)=C3)=N1)C(NC2=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Human pluripotent stem cell endothelial-cell differentiation
Human pluripotent stem cell endothelial differentiation is based on stepwise developmental patterning: early activation of WNT/GSK3β inhibition promotes mesodermal or vascular progenitor entry, followed by endothelial specification using VEGF-related signaling, BMP4, FGF2, Notch modulation, or cAMP depending on the published protocol. Endothelial differentiation is read out by acquisition of CD31, CD34, VE-cadherin/CD144, KDR/VEGFR2, vWF, Tie2, NOS3, acetylated LDL uptake, tube/network formation, barrier function, and in vivo vessel-forming capacity where tested.
-
Vascular/Branching Fractal Analysis
Vascular/branching fractal analysis quantifies the geometric complexity of vessel trees or vascular networks from segmented 2D images, commonly by converting vessels into binary and/or skeletonized maps and estimating fractal dimension using box-counting or related approaches. Fractal dimension is interpreted as an image-derived readout of vascular branching complexity, space filling, or density, and has been applied to retinal photographs, fluorescein angiography, OCT angiography, capillary perfusion maps, and in vitro Matrigel angiogenesis networks. The assay readout is generated from vessel-positive pixels after image preprocessing, vessel segmentation, binarization, and optional skeletonization; reported outputs include fractal dimension, vessel density, branchpoint density, endpoint density, vessel length density, tortuosity, and generation-based branching metrics when VESGEN-style analysis is used. The biological interpretation is limited to quantitative vascular patterning and s
-
Endothelial Tube Formation Assay
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
-
Endothelial Cell Migration/Angiogenic Sprouting Assay
Endothelial cell migration and angiogenic sprouting assays are in vitro (and partially ex vivo-adapted) functional models that quantify the ability of endothelial cells to undergo coordinated migration, extracellular matrix invasion, and multicellular organization into capillary-like sprouts in response to pro-angiogenic stimuli such as VEGF, bFGF, or conditioned microenvironments. These assays are used to model early angiogenic events including tip-cell formation, directional migration, and lumen-like sprout extension, which collectively reflect angiogenic activation and vascular morphogenesis processes observed in vivo.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)